Nanosonics Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NNCSF research report →
About the company
Nanosonics Limited, in conjunction with its subsidiaries, functions as an infection prevention enterprise, serving both Australian and international markets. The company's core activities involve the production and supply of the trophon ultrasound probe disinfector, alongside its complementary consumables and accessories. Furthermore, Nanosonics is committed to the research, development, and market introduction of innovative infection control and decontamination products and related technologies.
- CEO
- Michael C. Kavanagh
- IPO
- 2012
- Employees
- 466
- HQ
- Macquarie Park, NSW, AU
Price Chart
- Market Cap
- $762.22M
- P/E
- 49.48
- P/S
- 4.83
- P/B
- 4.63
- EV/EBITDA
- 29.29
- Div Yield
- 0.00%
- Gross Margin
- 77.17%
- Op Margin
- 8.95%
- Net Margin
- 9.91%
- ROE
- 9.57%
- ROIC
- 7.04%
- Revenue
- $198.93M · 17.01%
- Net Income
- $20.68M · 59.39%
- EPS
- $0.07 · 62.38%
- Op Income
- $8.93M
- FCF YoY
- 73.99%
- 52W High
- $3.06
- 52W Low
- $2.01
- 50D MA
- $2.47
- 200D MA
- $2.60
- Beta
- 1.22
- Avg Volume
- 224
Get TickerSpark's AI analysis on NNCSF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our NNCSF coverage
Recent articles, reports, and earnings notes.
No research on NNCSF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NNCSF report →Similar companies
Peers in the same neighborhood.